...
首页> 外文期刊>Microbial Cell Factories >Highly selective synthesis of d -amino acids via stereoinversion of corresponding counterpart by an in vivo cascade cell factory
【24h】

Highly selective synthesis of d -amino acids via stereoinversion of corresponding counterpart by an in vivo cascade cell factory

机译:在体内级联电池厂通过对应对应的立体转化体的高度选择性合成D-amino酸

获取原文

摘要

d-Amino acids are increasingly used as building blocks to produce pharmaceuticals and fine chemicals. However, establishing a universal biocatalyst for the general synthesis of d-amino acids from cheap and readily available precursors with few by-products is challenging. In this study, we developed an efficient in vivo biocatalysis system for the synthesis of d-amino acids from l-amino acids by the co-expression of membrane-associated l-amino acid deaminase obtained from Proteus mirabilis (LAAD), meso-diaminopimelate dehydrogenases obtained from Symbiobacterium thermophilum (DAPDH), and formate dehydrogenase obtained from Burkholderia stabilis (FDH), in recombinant Escherichia coli. To generate the in vivo cascade system, three strategies were evaluated to regulate enzyme expression levels, including single-plasmid co-expression, double-plasmid co-expression, and double-plasmid MBP-fused co-expression. The double-plasmid MBP-fused co-expression strain Escherichia coli pET-21b-MBP-laad/pET-28a-dapdh-fdh, exhibiting high catalytic efficiency, was selected. Under optimal conditions, 75 mg/mL of E. coli pET-21b-MBP-laad/pET-28a-dapdh-fdh whole-cell biocatalyst asymmetrically catalyzed the stereoinversion of 150 mM l-Phe to d-Phe, with quantitative yields of over 99% ee in 24 h, by the addition of 15 mM NADP and 300 mM ammonium formate. In addition, the whole-cell biocatalyst was used to successfully stereoinvert a variety of aromatic and aliphatic l-amino acids to their corresponding d-amino acids. The newly constructed in vivo cascade biocatalysis system was effective for the highly selective synthesis of d-amino acids via stereoinversion.
机译:D-氨基酸越来越多地用作制作药物和精细化学物质的结构块。然而,为普遍合成来自廉价的副体的D-氨基酸的通用生物催化剂具有较少的副产物是具有挑战性的。在这项研究中,我们在体内生物发作体系中开发了一种高效的生物发作系统,用于通过从Proteus mirabilis(Laad),中间二氨基脲(Meso-Diaminopimelate)获得的膜相关的L-氨基酸脱氨酶的膜相关的L-氨基酸脱氨酶合成来自L-氨基酸的D-氨基酸在重组大肠杆菌中,由Symbibiagerium嗜热硫醇(DAPDH)中获得的脱氢酶,并甲壳甲酯从伯克德列尔稳定剂(FDH)中获得的脱氢酶。为了产生体内级联系统,评价了三种策略以调节酶表达水平,包括单质粒共同表达,双质粒共表达和双质粒MBP稠合的共同表达。选择具有高催化效率的双质粒MBP稠合的COUSE表达菌株大肠杆菌PET-21B-MBP-LAAD / PET-28A-DAPDH-FDH。在最佳条件下,75mg / ml大肠杆菌PET-21B-MBP-LAAD / PET-28A-DAPDH-FDH全细胞生物催化剂不对称地将150mM L-PHE的立体转化率催化为D-PHE,具有定量产量通过加入15毫米NADP和300mM甲酸盐,超过99%EE。此外,整个细胞生物催化剂用于成功地立体地将各种芳族和脂族L-氨基酸与它们相应的D-氨基酸成功。在体内级联的生物催化系统中新建的新构建是通过立体转化率的高选择性合成D-氨基酸的能量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号